Locus Cell Co., Ltd. (TPEX:6891)
Taiwan
· Delayed Price · Currency is TWD 28.50
-0.30 (-1.04%)
At close: Dec 5, 2025
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 5.70 billion as of December 5, 2025. Its market cap has increased by 16.56% in one year.
Market Cap
5.70B
Enterprise Value
4.95B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.50
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 5.70B, a decrease of -42.31%. That is a compound annual growth rate of -14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.70B | 42.86% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |